Peer-reviewedCC BYJTCVS open
Real-world outcomes of induction chemoimmunotherapy in patients with non-small cell lung cancer who have never smoked.
- 1Department of Surgery, UCSF, San Francisco, Calif.
- 2Department of General Internal Medicine, COPPER Center, Yale School of Medicine, New Haven, Conn.
- 3Department of Surgery, Yale School of Medicine, New Haven, Conn.
Related
- A stem-like chromatin program in small-cell lung cancer is associated with poor outcomes after chemoimmunotherapy
- Survival Outcomes of Post‐Induction Treatment Strategies in Patients With Partial Response Hypopharyngeal Squamous Cell Carcinoma: A Propensity Score‐Weighted Analysis
- Induction Chemoimmunotherapy Versus Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study
- A Retrospective Study of the Efficacy and Safety of Chemoimmunotherapy in Elderly Patients with Extensive-Stage Small Cell Lung Cancer.
- Lactate dehydrogenase to albumin ratio as a potential indicator of pathological response and prognosis in non-small cell lung cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery.
BibTeX
@article{baskin2026realworld,
title = {{Real-world outcomes of induction chemoimmunotherapy in patients with non-small cell lung cancer who have never smoked.}},
author = {Alison S Baskin and Maureen Canavan and Benjamin J Resio and Daniel J Boffa and Giorgio Caturegli},
journal = {JTCVS open},
year = {2026},
month = aug,
doi = {10.1016/j.xjon.2026.101983},
url = {https://europepmc.org/article/MED/42948098},
note = {CC BY},
}
RIS
TY - JOUR
TI - Real-world outcomes of induction chemoimmunotherapy in patients with non-small cell lung cancer who have never smoked.
AU - Alison S Baskin
AU - Maureen Canavan
AU - Benjamin J Resio
AU - Daniel J Boffa
AU - Giorgio Caturegli
PY - 2026
DA - 2026/08/03
JO - JTCVS open
DO - 10.1016/j.xjon.2026.101983
UR - https://europepmc.org/article/MED/42948098
SN - 2666-2736
ER -